The NMO Antibody (AQP4-IgG) test is a specialized diagnostic blood test used to detect antibodies against aquaporin-4 (AQP4), a water channel protein predominantly found in the central nervous system. This antibody is strongly associated with neuromyelitis optica (NMO), a rare autoimmune disorder that primarily affects the optic nerves and spinal cord. By identifying the presence of AQP4-IgG antibodies in a patient’s serum, healthcare providers can confirm or rule out NMO, distinguish it from other neurological disorders like multiple sclerosis, and guide timely clinical intervention.
In addition to diagnosis, this test plays an important role in disease management and research. It can help monitor the effectiveness of therapy, predict the risk of relapse, and contribute to studies on autoimmune neurological disorders. Being highly specific for NMO, the test reduces the likelihood of false positives from other conditions and provides actionable insights for both patients and healthcare providers.
Fasting
Not Required
Reporting Time
7-10 days
Gender
Male/Female
Age Group
5-99 yrs
HAEMATOLOGY
- Complete Hemogram
✔ Home collection available ✔ No hidden charges
Need help? Call 1800-123-4567
Kidney / Renal | Heart & Cardiac Health | Liver Test | Comprehensive Diabetes | Comprehensive Thyroid | Child & Adolescent Health | Women's Health | Men's Health | Cancer | Immunity & Allergy Test | Fever & Infection | Pancreas | Vitamins & Nutrition | Sexual Wellness/STDs | Bone & Joint Health | Hormonal | Urine & Stool Test | Infectious Diseases | Covid & Respiratory Health | Obesity & Metabolism | Dental & Oral Health | Eye & Vision Screening | Skin & Hair Health | Senior Citizen Checkups | Mental Health & Wellness | Autoimmune Disorder | Pregnancy & Fertility